Cargando…

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the Polycomb-repressive complex 2 (PRC2) that epigenetically silences gene transcription through histone H3 lysine trimethylation (H3K27me3). EZH2 has been implicated in stem cell maintenance and is overexpressed in hematological and sol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ott, Martina, Litzenburger, Ulrike M., Sahm, Felix, Rauschenbach, Katharina J., Tudoran, Ruxandra, Hartmann, Christian, Marquez, Victor E., von Deimling, Andreas, Wick, Wolfgang, Platten, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471855/ https://www.ncbi.nlm.nih.gov/pubmed/23077658 http://dx.doi.org/10.1371/journal.pone.0047663

Ejemplares similares

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
por: Ciarapica, Roberta, et al.
Publicado: (2011)

Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis
por: Cheng, Tianci, et al.
Publicado: (2018)

Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells
por: Yao, Yizhou, et al.
Publicado: (2016)

A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy
por: Khan, Nadia, et al.
Publicado: (2019)

Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
por: Hibino, S, et al.
Publicado: (2014)

Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
por: Priya, Aditi, et al.
Publicado: (2023)

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
por: Litzenburger, Ulrike M., et al.
Publicado: (2014)

Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
por: Fan, Kui, et al.
Publicado: (2022)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis
por: Bremer, Sebastian C. B., et al.
Publicado: (2022)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014)

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
por: Changchien, Yi-Che, et al.
Publicado: (2012)

Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018)

Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells
por: Böhm, Julian, et al.
Publicado: (2019)

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
por: Alajez, N M, et al.
Publicado: (2010)

Uropathogenic E.coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2)
por: Ting, Kenneth, et al.
Publicado: (2016)

Silencing the enhancer of zeste homologue 2, Ezh2, represses axon regeneration of dorsal root ganglion neurons
por: Guo, Ting-Ting, et al.
Publicado: (2021)

Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
por: Hou, Tsung-Yun, et al.
Publicado: (2017)

Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue
por: Hapugaswatta, Harsha, et al.
Publicado: (2020)

Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
por: Fujii, Satoshi, et al.
Publicado: (2008)

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012)

The Effect of Overexpression of the Enhancer of Zeste Homolog 1 (EZH1) Gene on Aristolochic Acid-Induced Injury in HK-2 Human Kidney Proximal Tubule Cells In Vitro
por: Wang, Liping, et al.
Publicado: (2019)

Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy
por: Mbefo, Martial, et al.
Publicado: (2021)

Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
por: Chen, Shuling, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
por: Lv, Yang-Fan, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
por: Sun, Si, et al.
Publicado: (2018)

Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
por: Wu, Susan C., et al.
Publicado: (2011)

Correction: Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer
por: Yetişir, Abdullah Evren, et al.
Publicado: (2023)

Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma
por: Zeng, Jing, et al.
Publicado: (2022)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vebd3g2v2m742bubkk4qa7ppkq